E. K. Barygin

E. K. Barygin

Auto-generated profile, based on publicly available information

E. K. Barygin

Almazov National Medical Research Center

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2025 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
ICI.G. Chomakhashvili
I.G. Chomakhashvili
KAK.YU. Afanasyeva
K.YU. Afanasyeva
AMAleksandr Marichev
Aleksandr Marichev
ARAleksey Radovskiy
Aleksey Radovskiy
YVYu.V. Valueva
Yu.V. Valueva
Objective: The study aimed to review the literature data on the recommended maximum concentrations of nitrogen dioxide during inhaled therapy with nitric oxide and to propose a general list of recommendations on safe therapy with inhaled nitric oxide. Methods: The systematic review was performed according to the PRISMA 2020 criteria. A search was carried out in databases Russian Science Citation Index, MedLine, Cochrane Library using the keywords “nitrogen dioxide”, “limit concentration”, “annual limit value”, “inhaled nitric oxide”. Results: The review included 28 articles, 20 sources from regulatory authorities setting hygiene standards, and 2 instructions for devices. Conclusion: For short periods of NO inhalation not exceeding one hour, the maximum permissible concentration of NO2 in the inhaled gas mixture may be defined as 5 ppm. In cases of NO inhalation not exceeding 24 hours, the maximum permissible concentration of NO2 in the inhaled mixture should be considered as 2 ppm. If the duration of NO inhalation exceeds 24 hours, the permissible concentration of NO2 in the inhaled gas mixture should be limited to 1 ppm. Received 29 November 2024. Revised 9 January 2025. Accepted 13 January 2025. FundingThis research was carried out within the state assignment “Development of a new device for supplying nitric oxide synthesized from atmospheric air into mechanical circulatory assist devices” No. 123021000129‑1. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: A.E. Bautin, A.A. Burov, Yu.V. ValuevaData collection and analysis: I.G. Chomakhashvili, K.Yu. Afanasyeva, D.A. Kozyrev, E.K. Barygin, G.N. Ablesimov, N.V. Badalyan, M.S. Zhuravleva, A.M. Pozhidaeva, A.A. Burov, Yu.V. ValuevaDrafting the article: I.G. Chomakhashvili, A.A. Burov, Yu.V. ValuevaCritical revision of the article: A.E. Bautin, A.O. Marichev, A.M. Radovskiy, A.A. BurovFinal approval of the version to be published: A.E. Bautin, I.G. Chomakhashvili, K.Yu. Afanasyeva, A.O. Marichev, A.M. Radovskiy, D.A. Kozyrev, E.K. Barygin, G.N. Ablesimov, N.V. Badalyan, M.S. Zhuravleva, A.M. Pozhidaeva, A.A. Burov, Yu.V. Valueva

8 February 2024 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
KAK.YU. Afanasyeva
K.YU. Afanasyeva
AMAleksandr Marichev
Aleksandr Marichev
ARAleksey Radovskiy
Aleksey Radovskiy
EBE.K. Barygin
E.K. Barygin
APA.M. Pozhidaeva
A.M. Pozhidaeva
BACKGROUND Toxic effects of nitric dioxide (NO2) released under nitric oxide (NO) inhalation limit the application of nitric oxide high-dose therapy of clinical conditions accompanied by increased pulmonary vascular resistance. OBJECTIVE To identify the combinations of safe NO and O2 concentrations in inhaled gas compound for nitric dioxide release in a model of NO insufflation through the «Tianox» apparatus into respiratory circuit. MATERIAL AND METHODS The study was performed on an experimental model. There were 360 measurements of NO2 content in 72 various combinations of NO and O2. RESULTS NO2 release depended on NO and O2 content in gas mixture. Multivariate regression analysis confirmed this fact. NO2 concentration <2 ppm was recognized as a safe value. ROC-analysis confirmed predictive ability of NO and O2 regarding toxic NO2 concentrations. In case of inhalation therapy through the «Tianox» apparatus with any NO concentrations (10—80 ppm), O2 content in gas mixture within 21—30% was safe. NO concentration <50 ppm is safe at any O2 content in gas mixture (21—100%). CONCLUSION There is a fundamentally new source of NO in the Tianox device (synthesis from atmospheric air). We obtained data on possible safe combinations of inhaled O2 and NO regarding NO2 release for effective clinical use of this device.

27 January 2024 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
AMAleksandr Marichev
Aleksandr Marichev
LKL. I. Karpova
L. I. Karpova
ARAleksey Radovskiy
Aleksey Radovskiy
EBE. K. Barygin
E. K. Barygin
MGM. L. Gordeev
M. L. Gordeev
INTRODUCTION: Plasma cell-free hemoglobin (Hbf) has a negative effect on the results of cardiac surgery. OBJECTIVE: Analysis of the dynamics of the Hbf during cardiosurgical operations with CPB. Identification of the main factors for increasing the Hbf. MATERIALS AND METHODS: A prospective, single-center, cohort study included 50 patients who underwent cardiac surgery with CPB. Hbf was monitored before surgery, during CPB (10 minutes after the start, then every 30 minutes) and every 6 hours for two days. RESULTS: An increase in Hbf levels was found in 90 % of surgical procedure. In 8 % of cases, hemolysis was mild (0.1 < Hbf ≤ 0.4 g/l), in 48 % — moderate (0.4 < Hbf < 1 g/l), severe (Hbf ≥ 1 g/l) was after 34 % of operations. After weaning from CPB Hbf rapidly decreases and after 12 hours drop to the preoperative level. Aortic cross-clamping is a risk factor with an odds ratio of 1.038 (p = 0.036). A positive correlation was established between the Hbf level and the duration of CPB (r = 0.76; p < 0.001). In ROC-analysis, a good predictive ability for development of severe hemolysis was demonstrated by the time of CPB: AUC 0.74 (p = 0.014) with a threshold value of 76 minutes. During CABG, severe hemolysis developed significantly less frequently than during valve corrections — 12.5 % versus 44.1 %, p = 0.026. Hbf content was significantly lower with an initial hemoglobin concentration < 140 g/l than in patients with an initial hemoglobin level ≥ 140 g/l — 0.7 (0.5; 0.95) g/l versus 0.9 (0.7; 1.28) g/l, p = 0.036. CONCLUSIONS: Hemolysis is typical for the cardiac surgeries with CPB. The time of aoral clamping and CPB, the type of surgcry, the hemoglobin content before surgcry have an impact on the severity of hemolysis.

22 February 2025 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
EBE. K. Barygin
E. K. Barygin
AMAleksandr Marichev
Aleksandr Marichev
ARAleksey Radovskiy
Aleksey Radovskiy
VOV. V. Osovskikh
V. V. Osovskikh
KAK. Yu. Afanasyeva
K. Yu. Afanasyeva
ABAndrei Evgen'evich Bautin
Andrei Evgen'evich Bautin
The use of cardiopulmonary bypass (CPB) technologies is often associated with ischemic and re-perfusion injury to the myocardium. The contact of patient’s blood with the surface of the extracorporeal circuit leads to platelets activation and often triggers a systemic inflammatory reaction. Nitric oxide (NO) is a signal molecule produced by the endothelium of blood vessels. Under normal circumstances, it prevents excessive activation and aggregation of platelets, thus providing an organ-protective effect. Currently, there is a considerable amount of data available about positive effects of use of inhaled NO. Nitric oxide delivery into oxygenators of artificial and assisted blood circulation. However, there is a limited amount of publications on effects of NO delivery into gas circuit of oxygenators of artificial and assisted blood circulation. The objective of this article was to summarize currently available information about effects of NO delivery into extracorporeal circuits oxygenators through extensive literature review.